Literature DB >> 30732989

The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.

Kun Nie1, Yuyuan Gao1, Mingjin Mei1, Manli Guo1, Zhiheng Huang1, Limin Wang1, Jiehao Zhao1, Yuhu Zhang2, Lijuan Wang3.   

Abstract

The purpose of this work is to investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson's disease (PD) subjects with mild cognitive impairment (PD-MCI) in the Chinese population and to analyze relevant risk factors for PD-MCI. A total of 234 non-dementia PD subjects were collected. Standardized neuropsychological assessments of overall cognitive level and four cognitive domains (memory, executive function, attention and visuospatial function) were performed using MDS Task Force diagnostic criteria for PD-MCI. PD-MCI subjects were further divided into four subgroups: nonamnestic single-domain impairment type (PD-naMCI-SD), nonamnestic multiple-domain impairment type (PD-naMCI-MD), amnestic single-domain impairment type (PD-aMCI-SD), and amnestic multiple-domain impairment type (PD-aMCI-MD). The clinical characteristics of and risk factors for all subgroups were analyzed. PD-MCI was found in 45.3% of the non-dementia PD subjects. Differences between the PD-MCI and PD with normal cognition groups with respect to age, age of onset, years of education, and motor symptom severity were significant (P < 0.05). The single-domain impairment type was the largest PD-MCI subgroup (52.83%). Memory and executive function impairment were most frequent (22.64% and 20.75%, respectively). Among the four subgroups, the number of years of education was significantly different (P = 0.003). The overall cognitive function in amnestic multiple-domain impairment type was significantly worse compared with that in those with single-domain impairment type. Regression analysis results showed that old age, high UPDRS-III score, and hyperhomocysteinemia were risk factors for PD-MCI, whereas high education level was a protective factor. Early prevention of MCI-related risk factors provides effective means to retard cognitive decline in PD patients.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical characteristics; Mild cognitive impairment; Parkinson’s disease; Risk factor; Subgrouping

Mesh:

Year:  2019        PMID: 30732989     DOI: 10.1016/j.jocn.2019.01.021

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  Cognition, motor symptoms, and glycolipid metabolism in Parkinson's disease with depressive symptoms.

Authors:  Cong Yao; Lichao Niu; Yun Fu; Xu Zhu; Junfeng Yang; Peng Zhao; Xiaoxiao Sun; Yanyan Ma; Shen Li; Jie Li
Journal:  J Neural Transm (Vienna)       Date:  2021-11-27       Impact factor: 3.850

2.  Parkinson's disease with mild cognitive impairment may has a lower risk of cognitive decline after subthalamic nucleus deep brain stimulation: A retrospective cohort study.

Authors:  Hutao Xie; Quan Zhang; Yin Jiang; Yutong Bai; Jianguo Zhang
Journal:  Front Hum Neurosci       Date:  2022-09-06       Impact factor: 3.473

3.  Beneficial Effects of Sagacious Confucius' Pillow Elixir on Cognitive Function in Senescence-Accelerated P8 Mice (SAMP8) via the NLRP3/Caspase-1 Pathway.

Authors:  Zhitao Hou; Fengjin Li; Jing Chen; Yitian Liu; Changyuan He; Meng Wang; Tingting Mei; Yue Zhang; Liying Song; Xianming Shao
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-06       Impact factor: 2.629

4.  Clinical classification systems and long-term outcome in mid- and late-stage Parkinson's disease.

Authors:  Emil Ygland Rödström; Andreas Puschmann
Journal:  NPJ Parkinsons Dis       Date:  2021-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.